vialroom

#tirzepatide 2025-10-18

Saturday15 messages4 participantstimes are UTC
Highlights from this day
  • belfast_bac — is there a reason to titrate slower than the four week schedule 19:29
  • assay_not_purity — at 12 my appetite went completely and i dropped back a step, eating nothing isnt a win 20:00
  • surpass_two — does the GIP arm actually explain the easier nausea or is that hand waving 21:15
BB

is there a reason to titrate slower than the four week schedule

wk 1-4    2.5mg
wk 5-8    5.0mg
wk 9-20   7.5mg   <- stayed here
wk 21-24  10.0mg  (no extra benefit for me)
wk 25+    7.5mg   (came back down)

dual agonist, GIP as well as GLP-1, thats the whole difference in one line

easier gi for me

AN

at 12 my appetite went completely and i dropped back a step, eating nothing isnt a win

wk 1-4    2.5mg
wk 5-8    5.0mg
wk 9-20   7.5mg   <- stayed here
wk 21-24  10.0mg  (no extra benefit for me)
wk 25+    7.5mg   (came back down)
BB

the trials titrated every four weeks to a target, most people here stop at whatever works

BB

the two compounds arent interchangeable week for week even if the effect ends up similar

Cited study
Continued Treatment with Tirzepatide for Maintenance of Weight Reduction (SURMOUNT-4)
JAMA · 2024
Randomised withdrawal after a 36-week lead-in. Pairs with STEP 4.
ST

SURMOUNT-OSA was the sleep apnoea trial and it is not a weight headline however its quoted

ST

went back to semaglutide after 19 months because the cost difference mattered more than the GI

ok so i argued the sweet spot was nonsense and then spent 18 months at 7.5 not needing more

does the GIP arm actually explain the easier nausea or is that hand waving

📉5🧪2🧊7